Late filing
Filing comparison
Regen BioPharma Inc told the SEC it could not file its quarterly report on time
Does not expect a significant change in results.
Evidence
- Anticipates significant change
- False
- Other periodic reports filed
- True
- Severity
- normal
- Source
- Form 12b-25 (notification of late filing)
- Why
- The company told the SEC it could not file a periodic report on time, using Form 12b-25.